Find your next paid study

Florida Atlantic UniversityNCT07127510

~$10 – $750

Actual pay is set by the research site.

CC-486 and Venetoclax for Acute Myeloid Leukemia

This is an open label, dose escalation Phase I single institution pilot study for relapsed and refractory AML patients using CC-486 (oral azacitidine) with ven…

AML

University of Colorado, DenverNCT05287568

~$150 – $3,000

Actual pay is set by the research site.

Mental HealthHealth ServicesEvidence Based Programs in Schools

Beliefs and Attitudes for Successful Implementation in Schools (BASIS) Optimization

The objective of the BASIS R34 pilot study is to test the impact of eBASIS in a randomized controlled trial (RCT). Consistent with IMPACT's IQM, the study test…

University of WashingtonNCT06672835

~$10 – $750

Actual pay is set by the research site.

ALS (Amyotrophic Lateral Sclerosis)TBI Traumatic Brain InjurySCI - Spinal Cord Injury+1 more

Cognixion Pass Through Study

The goal of this study is refine the usability of a BCI capable communication platform. The study will take place in the United States area and will enroll up…

~$10 – $1,125

Actual pay is set by the research site.

CognixionNCT07209943

Serial Advanced Magnetic Resonance Imaging (MRI) for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma

This study examines whether repeated magnetic resonance imaging (MRI)s scan helps identify changes in the tumor during radiation and chemotherapy treatment in …

Malignant Glioma

M.D. Anderson Cancer CenterNCT04771806

~$10 – $750

Actual pay is set by the research site.

Reduction of Severity and Duration of Pediatric Gastroenteritis Through Amino Acid Fortified Oral Rehydration Therapy

The goal of this clinical trial is to compare amino acid-fortified oral rehydration therapy (ORT) to the standard of care ORT in pediatric patients with acute …

Acute Gastroenteritis

Paul A BreslinNCT06137014

~$150 – $4,500

Actual pay is set by the research site.

An Adaptive Two-Part, Phase 1/2, Multi-Center, Double-Blinded, Randomized, Controlled Study of the Safety and Efficacy of Topically Applied PEP-TISSEEL in Participants With Chronic Radiation Ulcer

The goal of this clinical trial is to learn if drug Purified Exosome Product (PEP™) and Fibrin Sealant (TISSEEL® VH SD Kit) (PEP-TISSEEL) works to treat chroni…

Chronic Radiation Ulcer

~$150 – $4,200

Actual pay is set by the research site.

Rion Inc.NCT06793748

Post-COVID ConditionsObesity

Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation

The research in this VA Merit will examine the effects of obesity and Post-COVID Conditions (PCC) on physical functioning, health-related quality of life, and …

VA Office of Research and DevelopmentNCT05880108

~$10 – $675

Actual pay is set by the research site.

Phase 2

Phase II Trial of Targeted Radiation With no Castration for Mcrpc

This trial tests if the combination of comprehensive metastasis directed therapy delivered by a precision form of external beam radiotherapy (stereotactic abla…

Prostate Cancer

VA Office of Research and DevelopmentNCT06084338

~$75 – $1,800

Actual pay is set by the research site.

Upper Respiratory DiseaseInfluenzaViral Upper Respiratory Infection

A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Impact of IDP® Supplement on Respiratory Immune Health Outcomes During Cold and Flu Season in Older Individuals

The primary goal of this study is to observe the impact of the IDP® Supplement on the duration and severity of upper respiratory symptoms in older individuals …

~$10 – $1,050

Actual pay is set by the research site.

Quantec LtdNCT07431840

Phase 2

Phase II Biomarker Study of BND-22 in Combination With Cemiplimab in Solid Tumors

To study possible biomarkers that may be related to how SAR444881 works (either alone or when combined with cemiplimab) in participants with solid tumors.

Solid Tumors

M.D. Anderson Cancer CenterNCT06651593

~$75 – $2,000

Actual pay is set by the research site.

Refractory Solid TumorsRelapsed Solid TumorsRelapsed Neuroblastoma+3 more

A Phase 1/2 Clinical Trial of the Novel Topoisomerase I Inhibitor PEEL-224 as a Single Agent and in Combination With Vincristine and Temozolomide in Children With Refractory, Progressive or Relapsed Solid Tumors

The phase 1 primary objective is to determine the pediatric recommended phase 2 dose (RP2D) of PEEL-224 as a single agent (phase 1A) and in combination with vi…